新医疗 新征程:2018医疗创新创业跨年大趴

2018-01-10 MedSci MedSci原创

如果把医疗服务创新分为三个阶段,那么第一个阶段始于21世纪初,中国内地正式开放医疗市场,民营医院迎来了第一个黄金期;从2011年起,医疗服务创新搭上“互联网”的快车,开启第二阶段,这个时期很多互联网创业者自外围切入医疗服务环节,以挂号、轻问诊等开启了医疗+互联网的试水,并带来创业高潮。从2015年起,更多医疗从业者开始加入互联网医疗创业,对产业链条的深度参与和经验使他们思考,互联网技术如何能够真正


如果把医疗服务创新分为三个阶段,那么第一个阶段始于21世纪初,中国内地正式开放医疗市场,民营医院迎来了第一个黄金期;从2011年起,医疗服务创新搭上“互联网”的快车,开启第二阶段,这个时期很多互联网创业者自外围切入医疗服务环节,以挂号、轻问诊等开启了医疗+互联网的试水,并带来创业高潮。


从2015年起,更多医疗从业者开始加入互联网医疗创业,对产业链条的深度参与和经验使他们思考,互联网技术如何能够真正提升诊疗、检测或者临床研究的效率。


当第三阶段的医疗服务创新创业拉开帷幕,机会在哪儿?

"<既有很棒的传统管理经验,同时又具备了互联网精神>,这也是我认为医疗领域未来十年有机会颠覆既往格局的企业特质",一位医疗领域资深投资人这样说道。

当“互联网”也成为传统行业,“新医疗”悄然登场,即将拉开第三阶段的医疗服务创新!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741155, encodeId=f7dc1e41155a2, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sat Jun 02 22:10:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285513, encodeId=df951285513d5, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513814, encodeId=a72915138142b, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741155, encodeId=f7dc1e41155a2, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sat Jun 02 22:10:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285513, encodeId=df951285513d5, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513814, encodeId=a72915138142b, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1741155, encodeId=f7dc1e41155a2, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Sat Jun 02 22:10:00 CST 2018, time=2018-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285513, encodeId=df951285513d5, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1513814, encodeId=a72915138142b, content=<a href='/topic/show?id=2bc732010fd' target=_blank style='color:#2F92EE;'>#创业#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32010, encryptionId=2bc732010fd, topicName=创业)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631d10593130, createdName=ms9476844295372110, createdTime=Fri Jan 12 02:10:00 CST 2018, time=2018-01-12, status=1, ipAttribution=)]